Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering treatments for rare conditions.

The fatty membrane surrounding every living cell is a vibrant environment where countless biological processes take place.

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

Researchers have discovered that about 5% of adult cancers rely on a gene called PELO to survive, offering a promising drug ...

A recent paper published in Science magazine by researcher Blanca Barquera, Ph.D., professor of biological sciences at ...

In honor of Rare Disease Day on February 28, 2025, Morgan Lewis is publishing a series of posts on As Prescribed and Health ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...